U.S. market Closed. Opens in 6 hours 4 minutes

IMNM | Immunome, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
Revenue14.02MN/AN/AN/AN/AN/A
Cost of Revenue728.00K631.00K755.00K755.00K615.00KN/A
Gross Profit13.29M-631.00K-755.00K-755.00K-615.00KN/A
Operating Expenses122.82M36.90M25.20M12.26M10.35M7.74M
Selling, General & Admin19.66M13.63M11.09M4.78M1.52M866.00K
Research & Development103.16M23.27M14.11M7.49M8.82M6.88M
Other Operating Expenses23.09MN/A503.00KN/AN/AN/A
Operating Income-109.53M-36.90M-25.20M-12.26M-10.35M-7.74M
Other Expenses / Income2.72M5.00K493.00K-5.58M-96.00K-102.00K
Before Tax Income-106.81M-36.90M-24.71M-17.84M-10.44M-7.84M
Income Tax Expenses560.11K617.00K-242.00K-717.00K106.00K39.00K
Net Income-106.81M-37.51M-24.47M-17.12M-10.55M-7.84M
Interest ExpensesN/A5.00K10.00K38.00K106.00K141.00K
Basic Shares Outstanding19.84M12.13M11.54M3.39M5.74M4.39M
Diluted Shares Outstanding19.84M12.13M11.54M3.39M5.74M4.39M
EBITDA-108.80M-36.27M-24.70M-12.26M-9.72M-7.18M
EBITDA Margin-776.16%0.00%0.00%0.00%0.00%0.00%
EBIT-106.25M-36.89M-24.70M-17.80M-10.34M-7.67M
EBIT Margin-757.92%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙